Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician.

about

Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes.Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.

P2860

Q48015498-BD02C6F1-9B89-4010-A3A8-A53C25C1E842 Q48266508-AA186475-0BE5-42C3-802A-FC30F6CDADB9

P2860

Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician.

Item

http://www.wikidata.org/entity/Q38821464

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Sodium-glucose co-transporter ...... or the primary care physician.

@en

type

Item

label

Sodium-glucose co-transporter ...... or the primary care physician.

@en

prefLabel

Sodium-glucose co-transporter ...... or the primary care physician.

@en

P1476

Sodium-glucose co-transporter ...... or the primary care physician.

@en

P2093

Ajay Chaudhuri

http://www.w3.org/2001/XMLSchema#string

Paresh Dandona

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

SGLT2 Inhibitors May Predispose to Ketoacidosis

Molecular basis for glucose-galactose malabsorption

Glucose transporters in the 21st Century

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.

P31

scholarly article

review article

P356

10.1111/IJCP.12937

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28440009

http://www.w3.org/2001/XMLSchema#string

P921

maturity-onset diabetes of the young

P932

5518299

http://www.w3.org/2001/XMLSchema#string

Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician.

about

P2860

P2860

Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P31

P356

P433

P478

P5008

P577

P698

P921

P932